Arteriosclerosis and Thrombosis, Vol 13, 1139-1158, Copyright © 1993 by American Heart Association

ARTICLES

Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study

SA Brown, R Hutchinson, J Morrisett, E Boerwinkle, CE Davis, AM Gotto Jr and W Patsch
Department of Medicine, Duke University Medical Center, Durham, NC 27710.

The distributions of plasma lipids, lipoproteins, and apoproteins of 14,524 female and male black and white participants 45 to 64 years old in the Atherosclerosis Risk in Communities (ARIC) Study are presented. All specimens were analyzed at a central laboratory. Mean total cholesterol levels increased with increasing age across all ages from 204 to 229 mg/dL (12%) in women and from 208 to 213 mg/dL (2%) in men. Triglyceride levels increased with age in women, remained stable in men, and were higher in whites than blacks. High-density lipoprotein (HDL) cholesterol levels were higher in black and white women (range, 57 to 59 mg/dL) compared with black men (49 to 52 mg/dL) or white men (42 to 43 mg/dL). Cholesterol associated with HDL was distributed in a relatively constant proportion between HDL3 (70% to 76%) and HDL2 (24% to 30%) for all race/sex groups. Low-density lipoprotein (LDL) cholesterol levels increased with age in black (14.7%) and white (17.1%) women and in black (4.4%) and white (3.7%) men; more than 50% of all participants had LDL cholesterol levels > 130 mg/dL. Apoprotein A-I and B levels followed the same trends as HDL cholesterol and LDL cholesterol levels, respectively. Lipoprotein(a) [Lp(a)] levels were twice as high in blacks as in whites, and women's Lp(a) levels were higher than men's Lp(a) levels for each race. Menopause was associated with elevated total cholesterol, LDL cholesterol, apoprotein B, and Lp(a) levels, and hormone replacement medication use in postmenopausal subjects was associated with higher HDL cholesterol, triglyceride, and apoprotein A-I levels and lower LDL cholesterol, apoprotein B, and Lp(a) levels.

This article has been cited by other articles:

				E. S. Ford, C. Li, G. Zhao, W. S. Pearson, and A. H. Mokdad Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults Arch Intern Med, March 23, 2009; 169(6): 572 - 578. [Abstract] [Full Text] [PDF]

				J. Suk Danik, N. Rifai, J. E. Buring, and P. M. Ridker Lipoprotein(a), Hormone Replacement Therapy, and Risk of Future Cardiovascular Events J. Am. Coll. Cardiol., July 8, 2008; 52(2): 124 - 131. [Abstract] [Full Text] [PDF]

				H. R. Superko and S. King III Lipid Management to Reduce Cardiovascular Risk: A New Strategy Is Required Circulation, January 29, 2008; 117(4): 560 - 568. [Full Text] [PDF]

				J. C. Cohen, E. Boerwinkle, T. H. Mosley Jr., and H. H. Hobbs Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med., March 23, 2006; 354(12): 1264 - 1272. [Abstract] [Full Text] [PDF]

				C. M. Ballantyne, R. C. Hoogeveen, H. Bang, J. Coresh, A. R. Folsom, L. E. Chambless, M. Myerson, K. K. Wu, A. R. Sharrett, and E. Boerwinkle Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Ischemic Stroke in Middle-aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study Arch Intern Med, November 28, 2005; 165(21): 2479 - 2484. [Abstract] [Full Text] [PDF]

				N. R. Matthan, S. M. Jalbert, S. Lamon-Fava, G. G. Dolnikowski, F. K. Welty, H. R. Barrett, E. J. Schaefer, and A. H. Lichtenstein TRL, IDL, and LDL Apolipoprotein B-100 and HDL Apolipoprotein A-I Kinetics as a Function of Age and Menopausal Status Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1691 - 1696. [Abstract] [Full Text] [PDF]

				A. E. Sumner, K. B. Finley, D. J. Genovese, M. H. Criqui, and R. C. Boston Fasting Triglyceride and the Triglyceride-HDL Cholesterol Ratio Are Not Markers of Insulin Resistance in African Americans Arch Intern Med, June 27, 2005; 165(12): 1395 - 1400. [Abstract] [Full Text] [PDF]

				M. Gross, M. Steffes, D. R. Jacobs Jr, X. Yu, L. Lewis, C. E. Lewis, and C. M. Loria Plasma F2-Isoprostanes and Coronary Artery Calcification: The CARDIA Study Clin. Chem., January 1, 2005; 51(1): 125 - 131. [Abstract] [Full Text] [PDF]

				M. C. Carr, J. D. Brunzell, and S. S. Deeb Ethnic differences in hepatic lipase and HDL in Japanese, black, and white Americans: role of central obesity and LIPC polymorphisms J. Lipid Res., March 1, 2004; 45(3): 466 - 473. [Abstract] [Full Text] [PDF]

				C. M. Ballantyne, R. C. Hoogeveen, H. Bang, J. Coresh, A. R. Folsom, G. Heiss, and A. R. Sharrett Lipoprotein-Associated Phospholipase A2, High-Sensitivity C-Reactive Protein, and Risk for Incident Coronary Heart Disease in Middle-Aged Men and Women in the Atherosclerosis Risk in Communities (ARIC) Study Circulation, February 24, 2004; 109(7): 837 - 842. [Abstract] [Full Text] [PDF]

				J. E Roeters van Lennep, H.T. Westerveld, D.W. Erkelens, and E. E van der Wall Risk factors for coronary heart disease: implications of gender Cardiovasc Res, February 15, 2002; 53(3): 538 - 549. [Abstract] [Full Text] [PDF]

				J. Rubin, F. Paultre, C. H. Tuck, S. Holleran, R. G. Reed, T. A. Pearson, C. M. Thomas, R. Ramakrishnan, and L. Berglund Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and Caucasians J. Lipid Res., February 1, 2002; 43(2): 234 - 244. [Abstract] [Full Text] [PDF]

				F. Paultre, C. H. Tuck, B. Boden-Albala, D. E. Kargman, E. Todd, J. Jones, M. C. Paik, R. L. Sacco, and L. Berglund Relation of Apo(a) Size to Carotid Atherosclerosis in an Elderly Multiethnic Population Arterioscler Thromb Vasc Biol, January 1, 2002; 22(1): 141 - 146. [Abstract] [Full Text] [PDF]

				G. T Gerhard, S. L Connor, R. C Wander, and W. E Connor Plasma lipid and lipoprotein responsiveness to dietary fat and cholesterol in premenopausal African American and white women Am. J. Clinical Nutrition, July 1, 2000; 72(1): 56 - 63. [Abstract] [Full Text] [PDF]

				P. L. Chang, S. R. Lindheim, C. Lowre, M. Ferin, F. Gonzalez, L. Berglund, E. Carmina, M. V. Sauer, and R. A. Lobo Normal Ovulatory Women with Polycystic Ovaries Have Hyperandrogenic Pituitary-Ovarian Responses To Gonadotropin-Releasing Hormone-Agonist Testing J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 995 - 1000. [Abstract] [Full Text]

				G. T Gerhard, M R. Malinow, T. G DeLoughery, A. J Evans, G. Sexton, S. L Connor, R. C Wander, and W. E Connor Higher total homocysteine concentrations and lower folate concentrations in premenopausal black women than in premenopausal white women Am. J. Clinical Nutrition, August 1, 1999; 70(2): 252 - 260. [Abstract] [Full Text] [PDF]

				D. Boffelli, D. A. Zajchowski, Z. Yang, and R. M. Lawn Estrogen Modulation of Apolipoprotein(a) Expression. IDENTIFICATION OF A REGULATORY ELEMENT J. Biol. Chem., May 28, 1999; 274(22): 15569 - 15574. [Abstract] [Full Text] [PDF]

				E. Sbarouni, Z. S. Kyriakides, and D. T. Kremastinos The effect of hormone replacement therapy alone and in combination with simvastatin on plasma lipids of hypercholesterolemic postmenopausal women with coronary artery disease J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1244 - 1250. [Abstract] [Full Text] [PDF]

				L. Nie, S. Niu, G. L. Vega, L. T. Clark, A. Tang, S. M. Grundy, and J. C. Cohen Three polymorphisms associated with low hepatic lipase activity are common in African Americans J. Lipid Res., September 1, 1998; 39(9): 1900 - 1903. [Abstract] [Full Text]

				I. Jialal Evolving lipoprotein risk factors: lipoprotein(a) and oxidized low-density lipoprotein Clin. Chem., August 1, 1998; 44(8): 1827 - 1832. [Abstract] [Full Text] [PDF]

				H. T. Westerveld, J. E. R. van Lennep, H. W. O. R. van Lennep, A.-H. Liem, J. A. J. de Boo, Y. T. van der Schouw, and D. W. Erkelens Apolipoprotein B and Coronary Artery Disease in Women : A Cross-sectional Study in Women Undergoing Their First Coronary Angiography Arterioscler Thromb Vasc Biol, July 1, 1998; 18(7): 1101 - 1107. [Abstract] [Full Text] [PDF]

				T.-P. Tuomainen, K. Punnonen, K. Nyyssonen, and J. T. Salonen Association Between Body Iron Stores and the Risk of Acute Myocardial Infarction in Men Circulation, April 21, 1998; 97(15): 1461 - 1466. [Abstract] [Full Text] [PDF]

				G. L. Vega, L. T. Clark, A. Tang, S. Marcovina, S. M. Grundy, and J. C. Cohen Hepatic lipase activity is lower in African American men than in white American men: effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC) J. Lipid Res., January 1, 1998; 39(1): 228 - 232. [Abstract] [Full Text] [PDF]

				S.-J. Hwang, C. M. Ballantyne, A. R. Sharrett, L. C. Smith, C. E. Davis, A. M. Gotto Jr, and E. Boerwinkle Circulating Adhesion Molecules VCAM-1, ICAM-1, and E-selectin in Carotid Atherosclerosis and Incident Coronary Heart Disease Cases : The Atherosclerosis Risk In Communities (ARIC) Study Circulation, December 16, 1997; 96(12): 4219 - 4225. [Abstract] [Full Text]

				P. S. Bachorik, K. L. Lovejoy, M. D. Carroll, and C. L. Johnson Apolipoprotein B and AI distributions in the United States, 1988–1991: results of the National Health and Nutrition Examination Survey III (NHANES III) Clin. Chem., December 1, 1997; 43(12): 2364 - 2378. [Abstract] [Full Text] [PDF]

				B. R. Zysow, K. Kauser, R. M. Lawn, and G. M. Rubanyi Effects of Estrus Cycle, Ovariectomy, and Treatment with Estrogen, Tamoxifen, and Progesterone on Apolipoprotein(a) Gene Expression in Transgenic Mice Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1741 - 1745. [Abstract] [Full Text]

				S. P. Fortmann and S. M. Marcovina Lipoprotein(a), a Clinically Elusive Lipoprotein Particle Circulation, January 21, 1997; 95(2): 295 - 296. [Full Text]

				C. M. Burchfiel, R. D. Abbott, D. S. Sharp, J. D. Curb, B. L. Rodriguez, and K. Yano Distribution and Correlates of Lipids and Lipoproteins in Elderly Japanese-American Men: The Honolulu Heart Program Arterioscler Thromb Vasc Biol, November 1, 1996; 16(11): 1356 - 1364. [Abstract] [Full Text]

				S. Sunayama, H. Daida, H. Mokuno, H. Miyano, H. Yokoi, Y. J. Lee, H. Sakurai, and H. Yamaguchi Lack of Increased Coronary Atherosclerotic Risk Due to Elevated Lipoprotein(a) in Women >=55 Years of Age Circulation, September 15, 1996; 94(6): 1263 - 1268. [Abstract] [Full Text]

				A. P. Surguchov, G. P. Page, L. Smith, W. Patsch, and E. Boerwinkle Polymorphic Markers in Apolipoprotein C-III Gene Flanking Regions and Hypertriglyceridemia Arterioscler Thromb Vasc Biol, August 1, 1996; 16(8): 941 - 947. [Abstract] [Full Text]

				V. Guetta and R. O. Cannon III Cardiovascular Effects of Estrogen and Lipid-Lowering Therapies in Postmenopausal Women Circulation, May 15, 1996; 93(10): 1928 - 1937. [Full Text]

				H. N. Ginsberg, J. Jones, W. S. Blaner, A. Thomas, W. Karmally, L. Fields, D. Blood, and M. D. Begg Association of Postprandial Triglyceride and Retinyl Palmitate Responses With Newly Diagnosed Exercise-Induced Myocardial Ischemia in Middle-Aged Men and Women Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1829 - 1838. [Abstract] [Full Text]

				Council on Scientific Affairs Management of Disorders of Cholesterol, Triglyceride, and Lipoprotein Metabolism: Report 6 of the Council on Scientific Affairs Arch Fam Med, October 1, 1995; 4(10): 869 - 878. [Abstract] [PDF]

				W. Y. Craig, S. E. Poulin, G. E. Palomaki, L. M. Neveux, R. F. Ritchie, and T. B. Ledue Oxidation-Related Analytes and Lipid and Lipoprotein Concentrations in Healthy Subjects Arterioscler Thromb Vasc Biol, June 1, 1995; 15(6): 733 - 739. [Abstract] [Full Text]

				D. L. Rainwater, M. J. Ludwig, S. M. Haffner, and J. L. VandeBerg Lipid and Lipoprotein Factors Associated With Variation in Lp(a) Density Arterioscler Thromb Vasc Biol, March 1, 1995; 15(3): 313 - 319. [Abstract] [Full Text]